Digital intervention improves glycemic control in type 2 diabetes patients
This study evaluated the efficacy of a digital educational intervention for patients with Type 2 diabetes, finding significant improvements in various health metrics.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the efficacy of a digital educational intervention for patients with Type 2 diabetes, finding significant improvements in various health metrics.
This study evaluated the preliminary efficacy of a digital intervention, SMART, aimed at improving metabolic health in individuals with schizophrenia spectrum disorders, showing significant improvements in various health-related outcomes.
This study compared the Equil patch insulin pump and the Medtronic MMT-712 insulin pump in treating Type 2 diabetes, finding no significant differences in key outcomes.
This study evaluated the Fos Biomedical non-transdermal patch system's effects on cardio-metabolic health and sleep quality, finding no significant improvements in key outcomes.
This study evaluated the effectiveness of the Health Storylines mAPP for self-management among individuals with chronic illnesses in Baguio City, Philippines, finding no significant differences in self-management scores.
This study evaluated the impact of high-dose Vitamin D3 supplementation on insulin resistance and glycaemic parameters in adult males with type 2 diabetes, finding no significant differences in most outcomes.
This study evaluated the outcomes of intermittently scanned continuous glucose monitoring (isCGM 2.0) in children with type 1 diabetes, showing significant reductions in time below range.
A study on liraglutide 3 mg demonstrated significant weight loss in adults with obesity compared to a control group.
The study evaluated the addition of liraglutide to SGLT2 inhibitors and metformin in adults with type 2 diabetes, showing significant improvements in glycaemic control.
This study investigated the effects of liraglutide combined with CPAP on patients with Type 2 diabetes and severe obstructive sleep apnea, finding significant improvements in several health metrics.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.